Diversity and inclusion in clinical trials: Evolution throughout the development of an mRNA COVID-19 vaccine
Despite the importance of equitable representation in clinical trials, disparities persist with racial and ethnic minorities remaining largely underrepresented in trial populations. During the coronavirus disease 2019 (COVID-19) pandemic, wherein disease disproportionately affected racial and ethnic...
Saved in:
Main Authors: | Jameka Hill (Author), Diane Montross (Author), Melanie Ivarsson (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stability Modelling of mRNA Vaccine Quality Based on Temperature Monitoring throughout the Distribution Chain
by: Zoltán Kis
Published: (2022) -
mRNA as a Therapeutics: Understanding mRNA Vaccines
by: Ferdi Oğuz, et al.
Published: (2022) -
Development of mRNA rabies vaccines
by: Zixin Fang, et al.
Published: (2024) -
Vaccines: Origin and evolution throughout history
by: Maria de los Santos Onate Tenorio, et al.
Published: (2022) -
Recent Advancement in mRNA Vaccine Development and Applications
by: Nojoud Al Fayez, et al.
Published: (2023)